@onehottrail's testosterone and IQ claims, fact-checked
Quick answer
The video centers on a case where dramatically elevated SHBG, estimated at a floor of 130 nmol/L, produces high total testosterone above 1500 ng/dL while free testosterone falls to approximately 0.9% of total, well below the reference range of 1-3%. This pattern is clinically consistent with conditions like hyperthyroidism, hepatic pathology, or SHBG-elevating genetic variants rather than exceptional natural androgen production. Evaluating testosterone status requires free testosterone by equilibrium dialysis alongside SHBG, not total testosterone alone.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @onehottrail actually say?
The creator argues that a YouTuber with total testosterone above 1500 ng/dL is not the hormone demigod he appears to be. The real story, according to the creator, is massively elevated SHBG pushing free testosterone down to roughly 0.9% of total, well below the typical 1-3% range. The takeaway: "not completely healthy" and likely driven by a serious underlying medical condition.
The creator also floats a personal observation that they have "never seen a natural with total testosterone levels above 1100 ng/dL without something else going on." That's an anecdote, not a clinical finding, but it frames the broader point: chasing high total testosterone numbers without looking at free testosterone is a misleading way to evaluate hormonal health.
Does the science back this up?
Mostly yes, and on the SHBG mechanics specifically, the creator is on solid ground. SHBG binds testosterone with high affinity, rendering it biologically inactive. When SHBG rises sharply, total testosterone can look impressive while free testosterone, the fraction available to androgen receptors, stays mediocre or worse.
A free testosterone percentage of 0.9% of total is genuinely low. Reference ranges from Vermeulen et al. (1999, Journal of Clinical Endocrinology and Metabolism) place free testosterone at roughly 1.5-3% of total in healthy young men using equilibrium dialysis. Anderson et al. (1985, Clinical Chemistry) confirmed SHBG's dominant role in determining bioavailable testosterone. Conditions that dramatically elevate SHBG include hyperthyroidism, liver disease, and certain genetic variants. An SHBG of 130 nmol/L, which the creator estimates as a floor here, is roughly three times the upper end of most lab reference ranges, which run 10-57 nmol/L depending on the assay.
What did they get wrong (or right)?
The creator deserves credit for explaining why total testosterone alone is a poor diagnostic marker. That point is well supported in endocrinology literature and is frequently misunderstood by the fitness and TRT optimization community.
Where the creator oversteps is the back-of-envelope SHBG estimate. The math for estimating SHBG from total and free testosterone requires knowing the exact assay method, albumin concentration, and whether the 13.55 ng/dL free value came from direct immunoassay or equilibrium dialysis. Direct immunoassay notoriously overestimates free testosterone (Ly and Handelsman, 2005, Journal of Clinical Endocrinology and Metabolism). If the free value came from a direct assay, the creator's derived SHBG estimate could be significantly off.
The 1100 ng/dL personal ceiling for "natty" total testosterone is also presented as a universal rule. It isn't. Testosterone distributions in healthy men have fat tails. Some men with no pathology test above 1100 ng/dL, though they are rare. Presenting an observational threshold as a medical standard is a stretch.
What should you actually know?
If you are evaluating your own testosterone levels, total testosterone is a starting point, not a conclusion. Standard clinical workup includes free testosterone measured by equilibrium dialysis (the gold standard), SHBG, LH, FSH, and a metabolic panel to rule out liver or thyroid conditions driving SHBG elevation.
Elevated SHBG matters clinically. Men with high SHBG and consequently low free testosterone can experience symptoms of hypogonadism, including fatigue, reduced libido, and cognitive changes, even when their total testosterone reads as "optimal." Holst et al. (2016, European Journal of Endocrinology) found that free testosterone was a better predictor of hypogonadal symptoms than total testosterone in a large population sample.
The reverse is also true. A man on TRT with normal-looking total testosterone but suppressed SHBG may have a higher free fraction than his numbers suggest. Context, not a single number, drives clinical decision-making. Anyone optimizing testosterone should have these conversations with a licensed clinician, not calibrate their health against a YouTuber's labs.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 10 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For @onehottrail's testosterone and IQ claims, fact-checked, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
@onehottrail's testosterone and IQ claims, fact-checked is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video centers on a case where dramatically elevated SHBG, estimated at a floor of 130 nmol/L, produces high total testosterone above 1500 ng/dL while free testosterone falls to approximately 0.
FormBlends verdict
The video centers on a case where dramatically elevated SHBG, estimated at a floor of 130 nmol/L, produces high total testosterone above 1500 ng/dL while free testosterone falls to approximately 0.9% of total, well below the reference range of 1-3%. This pattern is clinically consistent with conditions like hyperthyroidism, hepatic pathology, or SHBG-elevating genetic variants rather than exceptional natural androgen production. Evaluating testosterone status requires free testosterone by equilibrium dialysis alongside SHBG, not total testosterone alone.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video centers on a case where dramatically elevated SHBG, estimated at a floor of 130 nmol/L, produces high total testosterone above 1500 ng/dL while free testosterone falls to approximately 0.9% of total, well below the reference range of 1-3%. This pattern is clinically consistent with conditions like hyperthyroidism, hepatic pathology, or SHBG-elevating genetic variants rather than exceptional natural androgen production. Evaluating testosterone status requires free testosterone by equilibrium dialysis alongside SHBG, not total testosterone alone.
- Free testosterone, not total testosterone, is the biologically active fraction that binds androgen receptors. A total testosterone above 1500 ng/dL can coexist with functionally low androgen activity if SHBG is severely elevated.
- SHBG above 100-130 nmol/L is approximately two to three times the upper end of most male reference ranges and warrants investigation for thyroid disorders, liver disease, or other SHBG-elevating pathology.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Free testosterone, not total testosterone, is the biologically active fraction that binds androgen receptors. A total testosterone above 1500 ng/dL can coexist with functionally low androgen activity if SHBG is severely elevated.
- SHBG above 100-130 nmol/L is approximately two to three times the upper end of most male reference ranges and warrants investigation for thyroid disorders, liver disease, or other SHBG-elevating pathology.
- Vermeulen et al. (1999, JCEM) established free testosterone at roughly 1.5-3% of total in healthy young men. A free fraction of 0.9% is clinically below this range regardless of how impressive the total number looks.
- Direct immunoassay for free testosterone significantly overestimates the true value compared to equilibrium dialysis (Ly and Handelsman, 2005, JCEM). Which method produced the 13.55 ng/dL figure cited in the video is unknown and affects the derived SHBG estimate.
- The 1100 ng/dL 'natty ceiling' the creator mentions is a personal observation, not a clinical standard. Some healthy men without pathology do test above this level, though they are statistical outliers.
- A complete testosterone workup includes total testosterone, free testosterone by equilibrium dialysis, SHBG, LH, FSH, albumin, and metabolic panel. Optimizing off a single number is how people miss the actual problem.
- Holst et al. (2016, European Journal of Endocrinology) found free testosterone was a better predictor of hypogonadal symptoms than total testosterone in a large population cohort, supporting the clinical priority the creator assigns to the free fraction.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
OneHot · Instagram creator
22.0K views on this video
Testosterone and IQ — #lastofthenattys #testosterone #testosteronebooster #naturaltestosterone #testosteronelevels #testosteroneboost #lowtestosterone #testosteroneoptimization #testosterona #testo
Sources & references
Citations extracted from our medical team's review. Click any citation to search PubMed.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by OneHot, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.